TXT
82
4
ADP
54
-4
ADM
47
2
PBI
68
2
MUR
36
3
HPE
75
7
D
41
-4
JBHT
65
2
V
52
2
CHRW
82
3
TGNA
53
-3
GIS
58
-2
LUV
68
2
TAP
29
-11
BEN
55
2
CCL
81
16
SCHW
64
6
HSY
43
2
AES
47
-3
MLM
67
4
TXT
82
4
ADP
54
-4
ADM
47
2
PBI
68
2
MUR
36
3
HPE
75
7
D
41
-4
JBHT
65
2
V
52
2
CHRW
82
3
TGNA
53
-3
GIS
58
-2
LUV
68
2
TAP
29
-11
BEN
55
2
CCL
81
16
SCHW
64
6
HSY
43
2
AES
47
-3
MLM
67
4
Financhill
Back

CBRE Global Real Estate Income Fund Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Sell
39

IGR
CBRE Global Real Estate Income Fund

Last Price:
$4.29
Seasonality Move:
-0.18%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Sell
39
CBRE Global Real Estate Income Fund (IGR) is a Sell

Is CBRE Global Real Estate Income Fund a Buy, Sell or Hold?

  • The current CBRE Global Real Estate Income Fund [IGR] share price is $4.28. The Score for IGR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • IGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IGR Stock Price Chart

What is CBRE Global Real Estate Income Fund's stock price today?

  • The CBRE Global Real Estate Income Fund share price today is $4.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGR is experiencing slight selling pressure.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

IGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 33.26 Sell
Chaikin Money Flow: -336894 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.31 - 4.65) Sell
Bollinger Bands (100): (4.6 - 5.12) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

IGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.29 Sell
20-day SMA: 4.43 Sell
50-day SMA: 4.7 Sell
200-day SMA: 4.96 Sell
8-day EMA: 4.32 Sell
20-day EMA: 4.42 Sell
50-day EMA: 4.54 Sell
200-day EMA: 3.05 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

CBRE Global Real Estate Income Fund Earnings Growth & IGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

CBRE Global Real Estate Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):